TERRY SMITH: Open Payments
NPI 1710952585 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,304 in 127 payments from 22 companies in 2025. Trend: 2023 $1,610 · 2024 $2,993 · 2025 $2,304
Food & beverage: $2,292Education: $13
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $290 |
| ABBVIE INC. | 21 | $271 |
| Vanda Pharmaceuticals Inc. | 7 | $206 |
| Paratek Pharmaceuticals, Inc. | 6 | $195 |
| Gilead Sciences, Inc. | 6 | $176 |
| Corcept Therapeutics | 13 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $136 |
| GlaxoSmithKline, LLC. | 6 | $120 |
| Lilly USA, LLC | 7 | $100 |
| Indivior Inc. | 5 | $99 |
Products named: AIRSUPRA, NUZYRA, Korlym, CAPLYTA, Epclusa, FANAPT, TRELEGY ELLIPTA, HETLIOZ.
Industry payments across KY — which companies pay providers there.
